Voiding Dysfunction in Transgender Patients: What We Know and What We Do Not Know

被引:0
|
作者
Gonzalez, Gabriela [1 ]
Anger, Jennifer T. [2 ]
机构
[1] Univ Calif Sacramento, Davis Sch Med, Dept Urol, Sacramento, CA USA
[2] Univ Calif San Diego, San Diego Sch Med, Dept Urol, La Jolla, CA 92121 USA
关键词
Genital reconstructive surgery; Gender affirming care; Vaginoplasty; Metoidioplasty; Phalloplasty; Urethral stricture; Urethrocutaneous fistula; Vaginal remnant; Voiding dysfunction; PENILE INVERSION VAGINOPLASTY; SEX REASSIGNMENT SURGERY; POSTOPERATIVE COMPLICATIONS; VAGINAL PROLAPSE; PHALLOPLASTY; REPAIR; FLAP;
D O I
10.1007/s11934-024-01234-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of ReviewTransgender and non-binary patients (TGNB) undergoing gender affirming genital surgery may experience perioperative voiding dysfunction. This review aims to outline and analyze literature about gender affirming pelvic surgery urinary complications, evaluation, and treatment.Recent FindingsIf a patient is seeking bottom surgery, then urinary goals and pre-operative symptoms should be discussed with respect to variable post-operative outcomes. Urologists should also be aware of the effect that gender affirming hormone therapy has on urinary symptoms. Urethral strictures and urethrocutaneous fistulae occur after feminizing and masculinizing procedures and may manifest as LUTS. Although there is no standardized approach for managing post-operative voiding issues, we present available options.SummaryThe evaluation of TGNB patients is ideally affirming and tailored to the patient. Long-term urinary and voiding outcomes measurements after vaginoplasty and phalloplasty are also needed, as current validated questionnaires do not capture these symptoms well in TGNB patients.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Food OIT What do we know, what don't we know, and what do we need to know?
    Ciaccio, Christina E.
    Bauer, Maureen Egan
    Nowak-Wegrzyn, Anna
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (02) : 118 - 119
  • [22] Protein particles: What we know and what we do not know
    Ripple, Dean C.
    Dimitrova, Mariana N.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (10) : 3568 - 3579
  • [23] What we know and what we do not know about DMN
    Figl, Kathrin
    Mendling, Jan
    Tokdemir, Gul
    Vanthienen, Jan
    ENTERPRISE MODELLING AND INFORMATION SYSTEMS ARCHITECTURES-AN INTERNATIONAL JOURNAL, 2018, 13
  • [24] MYELIN VESICLES - WHAT WE KNOW AND WHAT WE DO NOT KNOW
    SEDZIK, J
    BLAUROCK, AE
    JOURNAL OF NEUROSCIENCE RESEARCH, 1995, 41 (02) : 145 - 152
  • [25] Brain drain:: what we know and what we do not know
    Wachter, Bernd
    Formative Years of Scholars, 2006, 83 : 51 - 66
  • [26] Cold urticaria - What we know and what we do not know
    Maltseva, Natalya
    Borzova, Elena
    Fomina, Daria
    Bizjak, Mojca
    Terhorst-Molawi, Dorothea
    Kosnik, Mitja
    Kulthanan, Kanokvalai
    Meshkova, Raisa
    Thomsen, Simon Francis
    Maurer, Marcus
    ALLERGY, 2021, 76 (04) : 1077 - 1094
  • [27] What do we know and what don't we know?
    Fawcett, J
    PSYCHIATRIC ANNALS, 2006, 36 (01) : 5 - 6
  • [28] Propofol and children - what we know and what we do not know
    Rigby-Jones, Ann E.
    Sneyd, J. Robert
    PEDIATRIC ANESTHESIA, 2011, 21 (03) : 247 - 254
  • [29] Sleep and ADHD: what we know and what we do not know
    Cortese, Samuele
    SLEEP MEDICINE, 2015, 16 (01) : 5 - 6
  • [30] WHAT WE SHOULD KNOW IN RELATION TO WHAT WE DO KNOW
    Rice, Donald L.
    OCEANOGRAPHY, 2014, 27 (01) : 5 - 5